Reports for SIVEM PHARMACEUTICALS ULC
Company Name
SIVEM PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
378 |
|
| Actual shortage: | 25 (7%) | |
| Anticipated shortage: | 6 (2%) | |
| Avoided shortage: | 14 (4%) | |
| Resolved: | 333 (88%) | |
Discontinuation Reports |
107 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 100 (93%) | |
| Reversed: | 7 (7%) | |
Late reports |
83 (17%) |
|
Overdue reports |
4 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CARVEDILOL | 3.125MG | TABLET | Resolved | 2017-12-12 | 2018-11-08 | 32560 |
| CARVEDILOL | 3.125MG | TABLET | Resolved | 2020-02-26 | 2020-06-09 | 107216 |
| IRBESARTAN HCT | 300MG 12.5MG | TABLET | Resolved | 2020-10-16 | 2021-02-12 | 126603 |
| IRBESARTAN HCT | 300MG 25MG | TABLET | Resolved | 2020-10-16 | 2021-02-12 | 126606 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-11-06 | 2018-04-30 | 28134 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-11-06 | 2018-04-30 | 28137 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2018-11-12 | 2018-12-21 | 66695 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2019-04-01 | 2019-05-31 | 80249 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2020-03-11 | 2020-07-02 | 108484 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2020-03-17 | 2020-07-02 | 108850 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2020-10-16 | 2021-02-12 | 126597 |
| RANITIDINE | 300MG | TABLET | Resolved | 2018-02-26 | 2018-07-31 | 41106 |
| RANITIDINE | 300MG | TABLET | Resolved | 2018-05-01 | 2018-07-31 | 47849 |
| RANITIDINE | 300MG | TABLET | Resolved | 2019-09-17 | 2022-08-20 | 94081 |
| PREGABALIN | 300MG | CAPSULE | Resolved | 2018-05-04 | 2018-05-19 | 48427 |
| PREGABALIN | 300MG | CAPSULE | Resolved | 2021-08-11 | 2021-10-19 | 143950 |
| QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Avoided shortage | 2017-04-27 | 2017-05-18 | 8290 |
| QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-06 | 2018-03-26 | 28287 |
| QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-08-05 | 2020-10-09 | 121787 |
| QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-01-31 | 2024-04-03 | 217998 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL SUSPENSION | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2017-06-06 | 2017-06-07 | 12022 |
| AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL SUSPENSION | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2017-06-06 | 2017-06-07 | 12025 |
| AMOXICILLIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2017-06-06 | 2017-06-07 | 12028 |
| AMOXICILLIN | 250MG | CAPSULE | Discontinued | 2018-06-12 | 2018-09-11 | 52192 |
| VALSARTAN HCT | 25MG 320MG | TABLET | Discontinued | 2019-09-18 | 2020-01-09 | 94211 |
| ATENOLOL | 25MG | TABLET | Discontinued | 2017-06-06 | 2017-12-12 | 11977 |
| PREGABALIN-25 | 25MG | CAPSULE | Discontinued | 2017-06-06 | 2017-06-07 | 12000 |
| ATENOLOL | 25MG | TABLET | Discontinued | 2017-11-06 | 2017-11-07 | 28199 |
| ATENOLOL | 25MG | TABLET | Discontinued | 2017-11-06 | 2017-11-07 | 28202 |
| PREGABALIN | 25MG | CAPSULE | Reversed | 2018-06-29 | 2022-02-14 | 53357 |
| AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2018-11-09 | 2019-09-18 | 66495 |
| AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2018-11-09 | 2019-09-18 | 66498 |
| METOPROLOL-L | 25MG | TABLET | Reversed | 2019-01-03 | 2022-02-14 | 70950 |
| METOPROLOL-L | 25MG | TABLET | Reversed | 2019-01-03 | 2022-02-14 | 70953 |
| METOPROLOL-L | 25MG | TABLET | Reversed | 2019-08-05 | 2022-02-14 | 90719 |
| LORAZEPAM | 2MG | TABLET | Discontinued | 2017-06-06 | 2017-06-07 | 11983 |
| LORAZEPAM | 2MG | TABLET | Discontinued | 2017-06-06 | 2017-06-07 | 11986 |
| CLONAZEPAM | 2MG | TABLET | Discontinued | 2017-11-06 | 2017-11-06 | 28160 |
| CLONAZEPAM | 2MG | TABLET | Discontinued | 2017-11-06 | 2017-12-12 | 28163 |
| QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-03-26 | 2018-03-26 | 44061 |